SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001424884-17-000083
Filing Date
2017-10-18
Accepted
2017-10-18 16:48:39
Documents
52
Period of Report
2017-08-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT ON FORM 10-Q quarterly_report.htm 10-Q 596828
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 17843
3 EXHIBIT 32.1 ex32_1.htm EX-32.1 7157
  Complete submission text file 0001424884-17-000083.txt   2451081

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT qbio-20170831.xml EX-101.INS 394290
5 XBRL TAXONOMY EXTENSION SCHEMA qbio-20170831.xsd EX-101.SCH 26870
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE qbio-20170831_cal.xml EX-101.CAL 34091
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE qbio-20170831_def.xml EX-101.DEF 51356
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE qbio-20170831_lab.xml EX-101.LAB 183851
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qbio-20170831_pre.xml EX-101.PRE 145582
Mailing Address 501 MADISON AVE. 14TH FLOOR NEW YORK NY 10022
Business Address 501 MADISON AVE. 14TH FLOOR NEW YORK NY 10022 212-588-0022
Q BioMed Inc. (Filer) CIK: 0001596062 (see all company filings)

IRS No.: 464013793 | State of Incorp.: NV | Fiscal Year End: 1130
Type: 10-Q | Act: 34 | File No.: 000-55535 | Film No.: 171143016
SIC: 2834 Pharmaceutical Preparations